Á lódáil...
Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
OBJECTIVE: We studied the effect of long-term alglucerase/imiglucerase (Ceredase®/Cerezyme®, Genzyme, a Sanofi company, Cambridge, MA, USA) treatment on hematological, visceral, and bone manifestations of Gaucher disease type 1 (GD1). METHODS: The International Collaborative Gaucher Group (ICGG) Gau...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer Netherlands
2012
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3648688/ https://ncbi.nlm.nih.gov/pubmed/22976765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10545-012-9528-4 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|